Advanced Biomarkers: Therapeutic and Diagnostic Targets in Urticaria
نویسندگان
چکیده
منابع مشابه
Chronic Urticaria: Diagnostic and Therapeutic Challenges
OBJECTIVES After participating in the CME activity, primary care physicians should be able to: 1. Describe the clinical and histopathological differences between chronic urticaria and acute urticaria 2. Describe the leading identifiable causes of chronic urticaria 3. Understand how to perform diagnostic workup of chronic urticaria 4. Understand the available medical treatments of chronic urticaria
متن کاملThe role of miRNAs as diagnostic and therapeutic biomarkers in various cancers
According to the growing number of cancer fatalities and the complexity of the disease in diagnosis, prognosis and treatment, here we have reviewed one of the helpful and promising factors in the diagnosis and treatment of cancer. Micro-ribonucleic acids (miRNAs) are non-coding ribonucleic acids that are evolutionarily conserved and have a length of 18-25 nucleotides. miRNAs control the express...
متن کاملPotential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets
As one of the most commonly diagnosed cancers worldwide, colorectal adenocarcinoma often occurs sporadically in individuals aged 50 or above and there is an increase among younger patients under 50. Routine screenings are recommended for this age group to improve early detection. The multifactorial etiology of colorectal cancer consists of both genetic and epigenetic factors. Recently, studies ...
متن کاملMicroRNA signatures as diagnostic and therapeutic targets.
MicroRNAs (miRNAs) are short, noncoding RNA molecules capable of regulating gene expression at transcription and translation levels (1 ). Conserved throughout evolution, miRNAs participate in fundamental biologic processes including cell cycle, differentiation, development, metabolism, patterning, and aging. The human genome contains approximately 1000 miRNAs that are estimated to regulate a th...
متن کاملCSF biomarkers of AD: monitoring therapeutic targets
grounds, implying the presence of senile plaques and neurofibrillary tangles in the hippocampus and cerebral cortex. Brain autopsy studies indicate that these lesions are present in about 90% of patients clinically diagnosed by experienced physicians. The utility of biomarkers for enhancing diagnositic sensitivity for AD may consequently be relatively limited since clinical methods are generall...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Archives of Allergy and Immunology
سال: 2021
ISSN: 1018-2438,1423-0097
DOI: 10.1159/000515753